Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

1 September 2026

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

1 September 2026

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

1 September 2026

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

1 September 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

31 August 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 1
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript
News

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk1 September 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

Matthew Davey
President & Executive Chairman

Okay. I’d like to thank everyone for joining us today on our Full Year 2026 Results Webinar. It’s been a privilege to deliver the full year results to our shareholders over the last 12 months. I want to make just one point clear on the outset that today’s session is focused on the results. We’ll keep to that on the Tabcorp announcement, everything we’ve had to say in the announcement on August 10 has been said. The Board has unanimously recommended the scheme subject to the independent experts concluding it is in the shareholders’ best interest, and there’s no superior bid. Shareholders will receive the scheme booklet, including the expert’s report later this year, and that’s the document to make a decision on. I’m not going to add anything beyond that on today’s announcement.

Do you want to flip to the key slide here. Perfect. So over the last 12 months, the company has continued to deliver against the operating turnaround that we set in place several years ago. This is most dramatically shown through the positive EBITDA, up over 200% to $14.1 million over the last 12 months. In addition to that, revenue has grown at double digits on a constant currency basis. We’re proud of that. The racing industry is a difficult industry. And in some parts, it’s experiencing contraction. Other parts, it’s experiencing growth, and the company was able to deliver a solid growth in the top line.

In addition to that, gross margin also improved. We put forward long-term objectives of getting to a 70% gross profit margin. We

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

Pzena Focused Credit Opportunities Q2 2026 Commentary

Virtus KAR Small-Cap Growth Fund Q2 2026 Commentary

Ensurge Micropower ASA (ENMPF) Q2 2026 Earnings Call Transcript

Weekly Closed-End Fund Roundup (August 23, 2026)

Baron Generational Growth Fund Q2 2026 Portfolio Activity

Editors Picks

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

1 September 2026

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

1 September 2026

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

1 September 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

31 August 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Pzena Focused Credit Opportunities Q2 2026 Commentary

31 August 2026

Virtus KAR Small-Cap Growth Fund Q2 2026 Commentary

31 August 2026

Ensurge Micropower ASA (ENMPF) Q2 2026 Earnings Call Transcript

31 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.